SCHEMBL22028079

SCHEMBL22028079

C=CC=C=CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11294585 0.73
SCHEMBL5735544 0.71
SCHEMBL8593563 0.67
SCHEMBL2094167 0.65
SCHEMBL8220261 0.65
SCHEMBL20028559 0.64
SCHEMBL5656063 0.63
SCHEMBL11296885 0.61
SCHEMBL2576315 0.61
SCHEMBL8390409 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032669-B Orthoester compositions for affinity purification of oligonucleotides 安捷伦科技有限公司 2024-03-29 CN disclosed
US-20230322742-A1 ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES AGILENT TECHNOLOGIES, INC. 2023-10-12 US disclosed
US-20230122968-A1 ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES AGILENT TECHNOLOGIES, INC. 2023-04-20 US disclosed
US-11548876-B2 Orthoester compositions for affinity purification of oligonucleotides AGILENT TECHNOLOGIES, INC. (US) 2023-01-10 US disclosed
US-11299483-B2 Orthoester compositions for affinity purification of oligonucleotides AGILENT TECHNOLOGIES, INC. (US) 2022-04-12 US disclosed
US-20200190129-A1 ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES AGILENT TECHNOLOGIES, INC. 2020-06-18 US disclosed
US-20200181124-A1 ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES AGILENT TECHNOLOGIES, INC. 2020-06-11 US disclosed
CN-106057651-A METHODS OF FORMING DIFFERENT SIZED PATTERNS 爱思开海力士有限公司 2016-10-26 CN disclosed